Cancer
Malignant Esophageal Neoplasm
CI-CAN-00001127Explore in graph →
Top-level518 active trials6 approved drugs12 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001127Explore in graph →
Clinical trials
1,926 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (169)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00397904 | Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin | completed | Phase 2 | 16 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 25, 2015 | clinicaltrials |
| NCT01998347 | Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer | withdrawn | Phase 3 | 0 | Shantou University Medical CollegeOTHER | 1 | Nov 20, 2015 |
| clinicaltrials |
| NCT02325986 | Concurrent Radiotherapy and Weekly Chemotherapy of PF for Postoperative Locoregional Recurrence of Esophageal Cancer | unknown | Phase 2 | 46 | Sun Yat-sen UniversityOTHER | 1 | Nov 20, 2015 | clinicaltrials |
| NCT00109850 | S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer | terminated | Phase 2 | 22 | SWOG Cancer Research NetworkNETWORK | 1 | Nov 18, 2015 | clinicaltrials |
| NCT00011960 | Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery | completed | Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 1 | Nov 17, 2015 | clinicaltrials |
| NCT01135849 | B-Receptor Signaling in Cardiomyopathy | completed | — | 99 | Daniel BernsteinOTHER | 1 | Nov 17, 2015 | clinicaltrials |
| NCT02603159 | Different Cycles of Capecitabine Usage in Esophageal Cancer Concurrent Chemoradiotherapy(DCECRT) | unknown | Phase 3 | 200 | The First Affiliated Hospital of Henan University of Science and TechnologyOTHER | 1 | Nov 11, 2015 | clinicaltrials |
| NCT00754468 | Study of CryoSpray Ablation(TM)to Determine Treatment Effect, Depth of Injury, and Side Effects in the Esophagus.(ESODOI) | completed | Phase 4 | 7 | CSA Medical, Inc.INDUSTRY | 1 | Nov 4, 2015 | clinicaltrials |
| NCT01932580 | Pilot Study of Perioperative Docetaxel, Oxaliplatin, and 5-Fluorouracil (FLOT) in Gastroesophageal Adenocarcinoma | completed | Phase 2 | 10 | McGill UniversityOTHER | 1 | Oct 27, 2015 | clinicaltrials |
| NCT02586753 | Paclitaxel or S1 Plus Cisplatin in Concurrent Chemoradiotherapy for Squamous Cell Carcinoma of Esophagus | unknown | Phase 2 | 2 | Mianyang Central HospitalOTHER | 0 | Oct 26, 2015 | clinicaltrials |
| NCT01998230 | Early Oral Feeding Following Thoracolaparoscopic Oesophagectomy in Patients With Esophageal Cancer | completed | Phase 3 | 280 | Yin LiOTHER_GOV | 1 | Oct 16, 2015 | clinicaltrials |
| NCT02570893 | A Phase III Trail of Adjuvant Chemoradiotherapy Versus Adjuvant Radiotherapy in Esophageal Squamous Cell Carcinoma | unknown | Phase 3 | 366 | Zhejiang Cancer HospitalOTHER | 1 | Oct 7, 2015 | clinicaltrials |
| NCT00093652 | Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer | terminated | Phase 1 / Phase 2 | — | Roswell Park Cancer InstituteOTHER | 1 | Oct 6, 2015 | clinicaltrials |
| NCT00258323 | Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer | completed | Phase 2 | 80 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 30, 2015 | clinicaltrials |
| NCT00397384 | Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer | completed | Phase 1 | 43 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2015 | clinicaltrials |
| NCT01871636 | ESD Versus EMR for Treatment of Early Barrett's Adenocarcinoma | completed | N/A | 40 | Evangelisches Krankenhaus DüsseldorfOTHER | 1 | Sep 9, 2015 | clinicaltrials |
| NCT02461043 | Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell Carcinoma | unknown | Phase 3 | 386 | Chinese Academy of Medical SciencesOTHER | 1 | Sep 1, 2015 | clinicaltrials |
| NCT02490735 | CIK in Treating Patients With Esophageal Cancer | not yet recruiting | Phase 2 | 2,000 | The First People's Hospital of ChangzhouOTHER | 0 | Jul 7, 2015 | clinicaltrials |
| NCT00578071 | Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin w EBRT for Esophageal Cancer(POXX) | completed | Phase 1 / Phase 2 | 29 | Brian CzitoOTHER | 1 | Jul 2, 2015 | clinicaltrials |
| NCT02464930 | Evaluation of MicroRNA Expression in Blood and Cytology for Detecting Barrett's Esophagus and Associated Neoplasia | unknown | — | 220 | Midwest Biomedical ResearchOTHER | 1 | Jun 8, 2015 | clinicaltrials |
| NCT01301495 | Prospective Evaluation of a New Covered Metal Stent for Malignant Lesions of the Esophagus | withdrawn | Phase 2 | 0 | Weill Medical College of Cornell UniversityOTHER | 1 | Jun 3, 2015 | clinicaltrials |
| NCT02448953 | Two-field Versus Three-field Lymphadenectomy in Thoracic Esophageal Carcinoma Without Cervical Lymph Node Involvement | unknown | N/A | 786 | Chinese Academy of Medical SciencesOTHER | 1 | May 20, 2015 | clinicaltrials |
| NCT02448966 | Traditional Three-incision Esophagectomy Versus Minimally Invasive Thorascopic and Laparoscopic Esophagectomy | unknown | — | 1,000 | Chinese Academy of Medical SciencesOTHER | 1 | May 20, 2015 | clinicaltrials |
| NCT02448979 | Esophagectomy in Middle and Lower Thoracic Esophageal Cancer Patients Through Left Versus Right Transthoracic Approach | unknown | Phase 3 | 800 | Chinese Academy of Medical SciencesOTHER | 1 | May 20, 2015 | clinicaltrials |
| NCT00130689 | Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer | completed | Phase 2 | 43 | Dana-Farber Cancer InstituteOTHER | 1 | May 14, 2015 | clinicaltrials |
| NCT00019110 | Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00019435 | LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00019825 | Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT02133612 | Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma | completed | Phase 2 | 43 | Chinese Academy of Medical SciencesOTHER | 1 | Apr 14, 2015 | clinicaltrials |
| NCT02023541 | Proton Beam Therapy to Treat Esophageal Cancer | terminated | Phase 1 | 3 | Washington University School of MedicineOTHER | 1 | Apr 7, 2015 | clinicaltrials |
| NCT02409849 | Octreotide LAR as Maintenance Treatment for Patients With NEC | unknown | Phase 2 | 92 | Peking UniversityOTHER | 1 | Apr 7, 2015 | clinicaltrials |
| NCT00735345 | Chemotherapy Induction and Chemoradiotherapy in Patients With Esophageal Carcinoma | terminated | Phase 2 | 50 | Arbeitsgemeinschaft medikamentoese TumortherapieOTHER | 1 | Mar 9, 2015 | clinicaltrials |
| NCT02033538 | Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of Esophagus | withdrawn | Phase 2 | 0 | Zhejiang UniversityOTHER | 1 | Mar 5, 2015 | clinicaltrials |
| NCT02034968 | Nimotuzumab Plus Nab-paclitaxel and Cisplatin in Treating Patients With Advanced Esophageal Carcinoma | withdrawn | Phase 2 | 0 | Zhejiang UniversityOTHER | 1 | Mar 5, 2015 | clinicaltrials |
| NCT02041819 | Neoadjuvant Chemotherapy of Nimotuzumab Plus Nab-Paclitaxel in Squamous Cell Carcinoma of Esophagus | withdrawn | Phase 2 | 0 | Zhejiang UniversityOTHER | 1 | Mar 5, 2015 | clinicaltrials |
| NCT00909350 | Micro-RNA (miR) Expression in Upper Gastrointestinal Mucosal Tissue | completed | — | 10 | Mayo ClinicOTHER | 1 | Feb 12, 2015 | clinicaltrials |
| NCT02011594 | Phase II Study of Maintenance Treatment of Nimotuzumab for Advanced Esophageal Carcinoma | withdrawn | Phase 2 | 0 | Zhejiang UniversityOTHER | 1 | Feb 12, 2015 | clinicaltrials |
| NCT00525915 | Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma | completed | Phase 2 | 126 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 9, 2015 | clinicaltrials |
| NCT01766349 | Effect of CCRT on Respiratory Performance and Functional Capacity in Esophagus Cancer Patients | completed | — | 100 | Far Eastern Memorial HospitalOTHER | 1 | Feb 5, 2015 | clinicaltrials |
| NCT02355249 | Traditional Three Incisions vs Minimally Invasive Thoracol-laparoscopic Esophagectomy for Esophageal Cancer | unknown | Phase 3 | 648 | Chinese Academy of Medical SciencesOTHER | 1 | Feb 4, 2015 | clinicaltrials |
| NCT01760070 | Comparison of O-type Hybrid Knife and IT Knife in ESD | completed | N/A | 78 | Xijing Hospital of Digestive DiseasesOTHER | 1 | Jan 26, 2015 | clinicaltrials |
| NCT01995084 | In Vivo Assessment of Hypoxia in Gastro-intestinal Cancer Using 18F-HX4-PET: an Optimization and Reproducibility Study(HYPE) | completed | N/A | 32 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Jan 14, 2015 | clinicaltrials |
| NCT01158287 | Sorafenib. ICORG 06-41, V4 | completed | Phase 2 | 54 | Cancer Trials IrelandNETWORK | 1 | Dec 31, 2014 | clinicaltrials |
| NCT00716157 | Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation | completed | — | 40 | Thomas Jefferson UniversityOTHER | 1 | Dec 5, 2014 | clinicaltrials |
| NCT01770275 | UICC Classification of Esophageal Cancer | completed | — | 605 | Universitätsklinikum Hamburg-EppendorfOTHER | 1 | Nov 18, 2014 | clinicaltrials |
| NCT01858805 | Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer | completed | — | 123 | Universitätsklinikum Hamburg-EppendorfOTHER | 1 | Nov 18, 2014 | clinicaltrials |
| NCT00165490 | Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal Cancer | completed | Phase 2 | 19 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 10, 2014 | clinicaltrials |
| NCT01246960 | A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer | completed | Phase 2 | 168 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 8, 2014 | clinicaltrials |
| NCT00867477 | PMRR-NO: Pulmonary Metabolic Radiation Response Versus Exhaled Nitric Oxide | completed | Phase 2 | 163 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 28, 2014 | clinicaltrials |
| NCT00686569 | Mediastinal Microdialysis in Patients With Oesophageal or Cardia Cancer Treated by Resection | completed | — | 40 | Odense University HospitalOTHER | 1 | Aug 5, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Nov 25, 2015source: clinicaltrials